Cholesterol homeostasis in the hepatocyte
Journal of Clinical Lipidology · 2026-09
DOI: 10.1016/j.jacl.2026.09.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Lipidology, 2026-09. Verfasst von Justine Cole und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Canada (Cole, Pe…. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, Intramural Research Program.
Abstract (Originalsprache)
BACKGROUND: Hepatocytes must maintain both intracellular and whole-body cholesterol homeostasis. The conventional model of cholesterol homeostasis is based on studies in fibroblasts, a cell with limited inputs and outputs of cholesterol. In contrast to fibroblasts and other peripheral cells, cholesterol enters and exits the hepatocyte by multiple pathways. Accordingly, regulation of cholesterol homeostasis should not be assumed to be identical in peripheral cells and hepatocytes. BODY: At steady state, the mass of cholesterol that enters the hepatocyte in chylomicrons and high-density lipoprotein (HDL) approximates the mass of cholesterol excreted from the organism by hepatocytes per day. But this does not include the cholesterol delivered within apolipoprotein B-100 (apoB100) particles. This creates a substantial apparent imbalance between the cholesterol delivered to and excreted from the hepatocyte per day. Furthermore, substantial increases in cholesterol delivered to the hepatocyte in low-density lipoprotein do not result in substantial reductions in the synthesis of cholesterol or expression of low-density lipoprotein receptor, whereas uptake of chylomicron remnants does. The disposition of cholesterol from HDL particles also appears to follow a separate metabolic route within the hepatocyte. CONCLUSIONS: This analysis challenges the validity of the conventional model of cholesterol homeostasis in the hepatocyte. We hypothesize that the cholesterol delivered in apoB100 particles is largely channeled within the hepatocyte to be re-secreted in newly assembled apoB100 particles without this cholesterol fully equilibrating with the regulatory pool of cholesterol. The evidence for the channel model we envisage is incomplete. However, failure of the conventional model should stimulate new efforts to account for cholesterol homeostasis in hepatocytes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Canada (Cole, Pencina, Kiss, and Sniderman).
- Lipoprotein Metabolism Laboratory, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA (Zubiran).
- Department of Medicine, Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Canada (Cole, Pencina, Kiss, and Sniderman). Electronic address: allan.sniderman@mcgil…
Förderung
- National Institutes of Health
- Intramural Research Program
Zitieren
APA
Cole, J., Pencina, I., Kiss, R., Zubiran, R., & Sniderman, A. D. (2026). Cholesterol homeostasis in the hepatocyte. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2026.09.006
Vancouver
Cole J, Pencina I, Kiss R, Zubiran R, Sniderman AD. Cholesterol homeostasis in the hepatocyte. Journal of Clinical Lipidology. 2026. doi:10.1016/j.jacl.2026.09.006
BibTeX
@article{Cole2026,
author = {Cole, Justine and Pencina, Iana and Kiss, Robert and Zubiran, Rafael and Sniderman, Allan D},
title = {Cholesterol homeostasis in the hepatocyte},
journal = {Journal of Clinical Lipidology},
year = {2026},
doi = {10.1016/j.jacl.2026.09.006}
}
EUVIMED